Ertapenem Sodium vs. Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections (0826-037)

NCT00389987 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Complicated Intra-Abdominal Infections

Interventions

DRUG: MK0826, /Duration of Treatment : 8 Weeks
DRUG: Comparator : piperacillin sodium (+) tazobactam sodium /Duration of Treatment : 8 Weeks

Sponsor

Merck Sharp & Dohme LLC